Offer - Urjas Oil for just ₹ 1
Mabtas N 100 Injection, a prescription drug, is manufactured in various forms such as Injection. Primarily, it is used for the treatment of Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia. Other than this, Mabtas N 100 Injection has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Mabtas N 100 Injection. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
The side effects typically associated with Mabtas N 100 Injection include Weakness. While these are the most often observed Mabtas N 100 Injection side effects, there are can be others also. These have been listed below. Such side effects of Mabtas N 100 Injection normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Mabtas N 100 Injection has a Moderate effect for pregnant women and Severe effect on lactating mothers. Warnings related to Mabtas N 100 Injection's effects on the liver, heart and kidney, if any, have been listed below.
Individuals suffering from medical conditions like Hyperkalemia must refrain from the use of Mabtas N 100 Injection since this can cause severe adverse effects. Other conditions have been mentioned below in the Mabtas N 100 Injection contraindications section.
Additionally, Mabtas N 100 Injection may also adversely react with other medicines. A complete list of these interactions is given below.
In addition to the above precautions for Mabtas N 100 Injection, it is important to know that it is not safe while driving, and is not habit-forming.
Mabtas N 100 Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Mabtas N 100 Injection safe for pregnant women?
Mabtas N may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Mabtas N again without your doctor's advice.
Is the use of Mabtas N 100 Injection safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Mabtas N. It should only be taken after medical advice.
What is the effect of Mabtas N 100 Injection on the Kidneys?
There can be some harmful effects on your kidneys after taking Mabtas N. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Mabtas N 100 Injection on the Liver?
Mabtas N is not harmful for the liver.
What is the effect of Mabtas N 100 Injection on the Heart?
You may experience side effects on your heart after taking Mabtas N. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.
If you are suffering from any of the following diseases, you should not take Mabtas N 100 Injection unless your doctor advises you to do so -
Is this Mabtas N 100 Injection habit forming or addictive?
Mabtas N 100 Injection does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Mabtas N 100 Injection as you may feel sleepy.
Is it safe?
Mabtas N 100 Injection is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
Mabtas N 100 Injection is unable to treat or cure mental disorders.
Interaction between Food and Mabtas N 100 Injection
You can take Mabtas N 100 Injection with food.
Interaction between Alcohol and Mabtas N 100 Injection
Information about the interaction of Mabtas N 100 Injection and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rituxan (rituximab)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1106-1109
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 872